Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 113   

Articles published

4502 4,797.00 -22.00 (-0.46%)
price chart
BRIEF-Takeda Pharmaceutical Co Ltd receives positive CHMP opinion for ADCETRIS
May 27 Takeda Pharmaceutical Co Ltd : * Takeda receives positive CHMP opinion for ADCETRIS as consolidation treatment in post-transplant hodgkin lymphoma Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780).
Valeant rejected joint takeover bid from Takeda, TPG in spring: source
Valeant Pharmaceuticals International Inc (VRX.TO) received a joint takeover offer from Japan's Takeda Pharmaceutical Co Ltd (4502.T) and TPG Capital Management LP [TPG.UL] this spring that the Canadian drugmaker rejected, according to a source ...
Valeant Pharmaceuticals International Inc stock shoots up after report it ...  Financial Post
Prosetta Biosciences, Inc. And Takeda Pharmaceutical Company Limited, Enter ...
SAN FRANCISCO, May 2, 2016 /PRNewswire/ -- Prosetta Biosciences, Inc. (the "Company," or "Prosetta"), today announced that it has entered into a Feasibility and First Right of Negotiation Agreement (the "Agreement") with Takeda Pharmaceutical ...
Progress MN: Takeda Pharmaceutical Co. Limited
That was the case for the Minnesota division of Takeda, the Japan-based pharmaceutical giant, when it found a 215,000-square-foot building in Brooklyn Park that had previously been occupied by Baxalta, a spinoff company of Baxter International.
Takeda Pharmaceutical Posts FY Profit
(RTTNews.com) - Takeda Pharmaceutical Company Limited (TKPHF.PK) reported that its net profit attributable to the owners of the company for fiscal year 2015 was 80.2 million yen and 102 yen per share compared to net loss of 145.8 million euros and 185 ...
Will AstraZeneca and Takeda Pharmaceutical Survive FDA Ruling On Their Cardiac ...
The Food and Drug Administration (FDA) has issued a ruling in relation to heart failure associated with the use of DPP-4 inhibitor saxagliptin and alogliptin, drugs marketed by AstraZeneca and Takeda Pharmaceutical respectively. The FDA emphasizes for ...
Takeda and Teva Establish “Teva Takeda Yakuhin Ltd.” in Japan
JERUSALEM & OSAKA, Japan--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Takeda Pharmaceutical Company Limited (TSE:4502) announce the establishment of Teva Takeda Yakuhin Ltd. (“Teva Takeda Yakuhin”).
Takeda Pharmaceuticals U.S.A., Inc. Announces Plans to Transform Business ...
Also as part of the targeted focus, Takeda has created a General Medicine Business Unit, led by Senior Vice President Thomas Gibbs, most recently of Vanda Pharmaceuticals, to support operations and marketing of the company's medicines in the areas of ...
Takeda Pharmaceutical's (TKPHF) CEO Christophe Weber on Q4 2015 Results ...
Good day, everyone and welcome to the Conference Call of Takeda Pharmaceutical Co., Ltd. The conference today is held based on presentation materials available at the company's website.
BRIEF-Takeda Pharmaceutical and Prosetta Biosciences enter into agreement
May 2 Takeda Pharmaceutical Co Ltd. * Prosetta biosciences, inc. And takeda pharmaceutical company limited, enter into agreement to discover and develop novel compounds for neurodegenerative diseases Source text for Eikon: Further company ...